Addition of meperidine to intraperitoneal bupivacaine for analgesia after laparoscopic cholecystectomy

Basit Öğe Kaydı
dc.authorscopusid6603397675
dc.authorscopusid7006498929
dc.authorscopusid6506306004
dc.authorscopusid8560325700
dc.authorscopusid6701467427
dc.contributor.authorAlagöl A.
dc.contributor.authorÇolak A.
dc.contributor.authorTükenmez B.
dc.contributor.authorTuran F.N.
dc.contributor.authorPamukçu Z.
dc.date.accessioned2024-06-12T10:28:19Z
dc.date.available2024-06-12T10:28:19Z
dc.date.issued2002
dc.description.abstractThe analgesic efficacy, haemodynamic and side effects of meperidine added via intraperitoneal (IP) or intravenous IV route to bupivacaine which administered intraperitoneally were assessed after laparoscopic cholecystectomy. In ASA I-II physical status, 35 female and 30 male were enrolled the study. Standard premedication, induction and maintnance of anaesthesia were performed to all patients. At the end of the surgical procedure, patients in Group I (n=21) received % 0.5 bupivacaine 20 mL IP and % 09 NaCl 1 mL IV; patients in Group II (n=22) received % 0.5 bupivacaine 20 mL IP and meperidine 50 mg (1 mL) IV and, Group III (n=22), % 0.5 bupivacaine 20 mL IP and meperidine 50 mg (1 mL) IV Pain scores, duration of analgesia, analgesic supplements, mean arterial pressure and heart rate were assessed at 0 and 30 min., 1, 2, 4, 12 and 24 hr postoperatively. Three groups achieved sufficient analgesia; meperidine administered via IP route provided lower pain scores than IP bupivacaine only, at 0, 2, 12 and 24 hrs (p<0.05) and than IV meperidine group at 4, 12 and 24 hrs. Duration of analgesia and analgesic consumptions of groups did not differ statistically. Side effects did not differ among groups. As a result, it is concluded that, meperidine is effective when administered intraperitoneally and it causes lower pain scores when added to IP bupivacaine.en_US
dc.identifier.endpage308en_US
dc.identifier.issn1016-5150
dc.identifier.issue7en_US
dc.identifier.scopus2-s2.0-0036701430en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage304en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17169
dc.identifier.volume30en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofTurk Anesteziyoloji ve Reanimasyonen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBupivacaine; Intraperitoneal Administration; Laparoscopic Cholecystectomy; Meperidine; Postoperative Analgesiaen_US
dc.subjectBupivacaine; Pethidine; Adult; Anesthesia Induction; Anesthesiological Techniques; Article; Cholecystectomy; Clinical Article; Clinical Trial; Controlled Clinical Trial; Controlled Study; Drug Efficacy; Female; Hemodynamics; Human; Laparoscopic Surgery; Male; Pain Assessment; Postoperative Analgesia; Postoperative Pain; Premedication; Scoring System; Side Effecten_US
dc.titleAddition of meperidine to intraperitoneal bupivacaine for analgesia after laparoscopic cholecystectomyen_US
dc.title.alternativeLaparoskopik kolesistektomi sonrasi analjezide i?ntraperitoneal bupivakaine meperidin eklenmesien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu